These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 11389005)
41. Relapsed or refractory anaplastic large-cell lymphoma in children and adolescents after Berlin-Frankfurt-Muenster (BFM)-type first-line therapy: a BFM-group study. Woessmann W; Zimmermann M; Lenhard M; Burkhardt B; Rossig C; Kremens B; Lang P; Attarbaschi A; Mann G; Oschlies I; Klapper W; Reiter A J Clin Oncol; 2011 Aug; 29(22):3065-71. PubMed ID: 21709186 [TBL] [Abstract][Full Text] [Related]
42. Clinical characteristics and treatment results of pediatric B-cell non-Hodgkin lymphoma patients in a single center. Karadeniz C; Oguz A; Citak EC; Uluoglu O; Okur V; Demirci S; Okur A; Aksakal N Pediatr Hematol Oncol; 2007 Sep; 24(6):417-30. PubMed ID: 17710659 [TBL] [Abstract][Full Text] [Related]
43. The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Patte C; Auperin A; Michon J; Behrendt H; Leverger G; Frappaz D; Lutz P; Coze C; Perel Y; Raphaël M; Terrier-Lacombe MJ; Blood; 2001 Jun; 97(11):3370-9. PubMed ID: 11369626 [TBL] [Abstract][Full Text] [Related]
44. [Efficacy of modified B-NHL-BFM-90 protocol on anaplastic T-cell lymphoma in children and adolescents]. Sun XF; Zhen ZJ; Xiang XJ; Ling JY; Peng RJ; Xia Y; Zheng L; Luo WB; Lin H; Guan ZZ Ai Zheng; 2009 May; 28(5):506-10. PubMed ID: 19624879 [TBL] [Abstract][Full Text] [Related]
45. Anaplastic large cell lymphoma: a single institution experience from India. Lakshmaiah KC; Guruprasad B; Shah A; Kavitha S; Abraham LJ; Govindbabu K; Aruna Kumari BS; Appaji L J Cancer Res Ther; 2013; 9(4):649-52. PubMed ID: 24518711 [TBL] [Abstract][Full Text] [Related]
46. Effective preventive central nervous system therapy with extended triple intrathecal therapy and the modified ALL-BFM 86 chemotherapy program in an enlarged non-high risk group of children and adolescents with non-B-cell acute lymphoblastic leukemia: the Israel National Study report. Stark B; Sharon R; Rechavi G; Attias D; Ballin A; Cividalli G; Burstein Y; Sthoeger D; Abramov A; Zaizov R Cancer; 2000 Jan; 88(1):205-16. PubMed ID: 10618625 [TBL] [Abstract][Full Text] [Related]
47. [Efficacy of modified B-NHL-BFM-90 protocol on Burkitt's lymphoma in Chinese children and adolescents]. Sun XF; Zhen ZJ; Liu DG; Xia Y; Xiang XJ; Chen XQ; Ling JY; Zheng L; Luo WB; Lin H; He YJ; Guan ZZ Ai Zheng; 2007 Dec; 26(12):1339-43. PubMed ID: 18076797 [TBL] [Abstract][Full Text] [Related]
48. CD20 positive childhood B-non Hodgkin lymphoma (B-NHL): morphology, immunophenotype and a novel treatment approach: a single center experience. Bilić E; Femenić R; Konja J; Simat M; Dubravcić K; Batinić D; Ries S; Rajić L Coll Antropol; 2010 Mar; 34(1):171-5. PubMed ID: 20432747 [TBL] [Abstract][Full Text] [Related]
49. Pediatric non-Hodgkin lymphoma: a retrospective 14-year experience with Berlin-Frankfurt-Münster (BFM) protocols from a tertiary care hospital in Serbia. Dokmanovic L; Krstovski N; Vukanic D; Brasanac D; Rodic P; Cvetkovic M; Janic D Pediatr Hematol Oncol; 2012 Mar; 29(2):109-18. PubMed ID: 22376014 [TBL] [Abstract][Full Text] [Related]
50. Non-Hodgkin's lymphoma in pediatric patients with chromosomal breakage syndromes (AT and NBS): experience from the BFM trials. Seidemann K; Henze G; Beck JD; Sauerbrey A; Kühl J; Mann G; Reiter A Ann Oncol; 2000; 11 Suppl 1():141-5. PubMed ID: 10707797 [TBL] [Abstract][Full Text] [Related]
51. Long-term results of the first Italian Association of Pediatric Hematology and Oncology protocol for the treatment of pediatric B-cell non-Hodgkin lymphoma (AIEOP LNH92). Pillon M; Di Tullio MT; Garaventa A; Cesaro S; Putti MC; Favre C; Lippi A; Surico G; Di Cataldo A; D'Amore E; Zanesco L; Rosolen A Cancer; 2004 Jul; 101(2):385-94. PubMed ID: 15241838 [TBL] [Abstract][Full Text] [Related]
52. The addition of etoposide to CHOP is associated with improved outcome in ALK+ adult anaplastic large cell lymphoma: A Nordic Lymphoma Group study. Cederleuf H; Bjerregård Pedersen M; Jerkeman M; Relander T; d'Amore F; Ellin F Br J Haematol; 2017 Sep; 178(5):739-746. PubMed ID: 28485010 [TBL] [Abstract][Full Text] [Related]
53. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Reiter A; Schrappe M; Ludwig WD; Hiddemann W; Sauter S; Henze G; Zimmermann M; Lampert F; Havers W; Niethammer D Blood; 1994 Nov; 84(9):3122-33. PubMed ID: 7949185 [TBL] [Abstract][Full Text] [Related]
54. Therapy for non-Hodgkin lymphoma in children with primary immunodeficiency: analysis of 19 patients from the BFM trials. Seidemann K; Tiemann M; Henze G; Sauerbrey A; Müller S; Reiter A Med Pediatr Oncol; 1999 Dec; 33(6):536-44. PubMed ID: 10573576 [TBL] [Abstract][Full Text] [Related]
55. Intensive chemotherapy without radiotherapy gives more than 85% event-free survival for non-Hodgkin lymphoma without central nervous involvement: a 6-year population-based study from the nordic society of pediatric hematology and oncology. Márky I; Björk O; Forestier E; Jónsson OG; Perkkiö M; Schmiegelow K; Storm-Mathiesen I; Gustafsson G; J Pediatr Hematol Oncol; 2004 Sep; 26(9):555-60. PubMed ID: 15342981 [TBL] [Abstract][Full Text] [Related]
56. Favorable outcome for children and adolescents with T-cell lymphoblastic lymphoma with an intensive ALL-type therapy without local radiotherapy. Grenzebach J; Schrappe M; Ludwig WD; Parwaresch R; Zimmermann M; Gadner H; Riehm H; Reiter A; Ann Hematol; 2001; 80 Suppl 3():B73-6. PubMed ID: 11757713 [TBL] [Abstract][Full Text] [Related]
57. Anaplastic large-cell lymphoma: clinical and prognostic evaluation of 90 adult patients. Zinzani PL; Bendandi M; Martelli M; Falini B; Sabattini E; Amadori S; Gherlinzoni F; Martelli MF; Mandelli F; Tura S; Pileri SA J Clin Oncol; 1996 Mar; 14(3):955-62. PubMed ID: 8622045 [TBL] [Abstract][Full Text] [Related]
58. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica. Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi AM; Messina C; Mori PG; Miniero R; Colella R; Basso G J Clin Oncol; 1995 Oct; 13(10):2497-502. PubMed ID: 7595699 [TBL] [Abstract][Full Text] [Related]
59. Treatment of children with B-cell non-Hodgkin's lymphoma in developing countries: the experience of a single center in Brazil. Klumb CE; Schramm MT; De Resende LM; Carriço MK; Coelho AM; de Meis E; Ferreira RM; Maia RC; Dobbin Jde A J Pediatr Hematol Oncol; 2004 Jul; 26(7):462-8. PubMed ID: 15218425 [TBL] [Abstract][Full Text] [Related]
60. Efficacy of peripheral blood stem cell transplantation versus conventional chemotherapy on anaplastic large-cell lymphoma:a retrospective study of 64 patients from a single center. He XH; Li B; Zou SM; Dong M; Zhou SY; Yang JL; Xue LY; Yang S; Liu P; Qin Y; Zhang CG; Han XH; Shi YK Chin J Cancer; 2012 Nov; 31(11):532-40. PubMed ID: 22854061 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]